[
  {
    "ts": null,
    "headline": "Biotech Leader Stoke Therapeutics Offers Multiple Entries As Revenue Surges 117%",
    "summary": "Biotech leader Stoke stock is running up toward a new buy point. The company's revenue surged 117% in Q3.",
    "url": "https://finnhub.io/api/news?id=68f7c63225118dbe9d32e3a48d4c7c4d92e99825fe5f48fe10cf2c73855cc8b0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765908929,
      "headline": "Biotech Leader Stoke Therapeutics Offers Multiple Entries As Revenue Surges 117%",
      "id": 137806929,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "Biotech leader Stoke stock is running up toward a new buy point. The company's revenue surged 117% in Q3.",
      "url": "https://finnhub.io/api/news?id=68f7c63225118dbe9d32e3a48d4c7c4d92e99825fe5f48fe10cf2c73855cc8b0"
    }
  }
]